The remarkable significantly higher prevalence of IgM to PI, PS, and CL in APS patients suffering from TIA and of IgM to PI and CL in APS patients with TIA and/or ischemic stroke warrants further investigation. The gene discussed is CD40LG; the disease is autoimmune polyendocrinopathy.